IRIS Accounts Production v25.1.0.734 13190826 director 1.3.24 28.2.25 28.2.25 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh131908262024-02-29131908262025-02-28131908262024-03-012025-02-28131908262023-02-28131908262023-03-012024-02-29131908262024-02-2913190826ns15:EnglandWales2024-03-012025-02-2813190826ns14:PoundSterling2024-03-012025-02-2813190826ns10:Director12024-03-012025-02-2813190826ns10:PrivateLimitedCompanyLtd2024-03-012025-02-2813190826ns10:Micro-entities2024-03-012025-02-2813190826ns10:AuditExempt-NoAccountantsReport2024-03-012025-02-2813190826ns10:FullAccounts2024-03-012025-02-2813190826ns10:RegisteredOffice2024-03-012025-02-2813190826ns5:CurrentFinancialInstruments2025-02-2813190826ns5:CurrentFinancialInstruments2024-02-29131908261ns10:Director12024-02-29131908261ns10:Director12023-02-28131908261ns10:Director12024-03-012025-02-28131908261ns10:Director12023-03-012024-02-29131908261ns10:Director12025-02-28131908261ns10:Director12024-02-29
REGISTERED NUMBER: 13190826 (England and Wales)















Unaudited Financial Statements for the Year Ended 28 February 2025

for

JT CLINICAL SYSTEMS CONSULTANCY
LIMITED

JT CLINICAL SYSTEMS CONSULTANCY
LIMITED (by shares) (Registered number: 13190826)






Contents of the Financial Statements
for the Year Ended 28 February 2025




Page

Company Information 1

Balance Sheet 2


JT CLINICAL SYSTEMS CONSULTANCY
LIMITED (by shares)

Company Information
for the Year Ended 28 February 2025







DIRECTOR: J Hussain





REGISTERED OFFICE: Mansion House
Manchester Road
Altrincham
Cheshire
WA14 4RW





REGISTERED NUMBER: 13190826 (England and Wales)






JT CLINICAL SYSTEMS CONSULTANCY
LIMITED (by shares) (Registered number: 13190826)

Balance Sheet
28 February 2025

28.2.25 29.2.24
£    £    £    £   
FIXED ASSETS 1,306 833

CURRENT ASSETS 69,842 78,132

CREDITORS
Amounts falling due within one year (13,133 ) (24,440 )
NET CURRENT ASSETS 56,709 53,692
TOTAL ASSETS LESS CURRENT
LIABILITIES

58,015

54,525

CAPITAL AND RESERVES 58,015 54,525

NOTES TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2024 - 1 ) .

2. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28 February 2025 and 29 February 2024:

28.2.25 29.2.24
£    £   
J Hussain
Balance outstanding at start of year - -
Amounts advanced 251 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 251 -



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

JT CLINICAL SYSTEMS CONSULTANCY
LIMITED (by shares) (Registered number: 13190826)

Balance Sheet - continued
28 February 2025


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 8 April 2025 and were signed by:





J Hussain - Director